Pharmaceutical composition and application for combination antiviral therapy

The invention discloses a kind of pharmaceutical composition for combination antiviral therapy, wherein containing at least one non-nucleoside reverse transcriptase inhibitor ACC007 as active component, and the pharmaceutically useful excipient with specific quantitative component ratio；The active component selected from other non-nucleoside reverse transcriptase inhibitors, nucleosides (acid) class RTI, protease inhibitors, integrase inhibitor, fusion/entry inhibitor and coreceptor inhibitor can also be included.The invention also discloses application of the aforementioned pharmaceutical compositions in antiviral and anti-hiv therapy.Prior art is compared to, synergy well is generated after pharmaceutical composition combination of the invention, expanded the product of the infection for the treatment of virus, particularly HIV；Every consumption per day of other ACC007 is small, can greatly reduce the amount of excipient, facilitates patient to use, and improves patient's drug compliance, reduces the generation of resistance phenomenon, increases the curative effect of AntiHIV1 RT activity.